Literature DB >> 31060120

2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.

.   

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection is high in middle-aged and elderly patients. These practice guidelines will provide useful and constructive advice for the clinical management of patients with HCC. A total of 44 experts in hepatology, oncology, surgery, radiology and radiation oncology in the Korean Liver Cancer Association-National Cancer Center Korea Practice Guideline Revision Committee revised the 2014 Korean guidelines and developed new recommendations that integrate the most up-to-date research findings and expert opinions.

Entities:  

Keywords:  Carcinoma; Diagnosis; Guidelines; Management; hepatocellular

Mesh:

Year:  2019        PMID: 31060120      PMCID: PMC6529163          DOI: 10.5009/gnl19024

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  710 in total

1.  Radiation therapy for abdominal lymph node metastasis from hepatocellular carcinoma.

Authors:  Young Je Park; Do Hoon Lim; Seung Woon Paik; Kwang Cheol Koh; Joon Hyoek Lee; Moon Seok Choi; Byung Chul Yoo; Hee Rim Nam; Dong Ryul Oh; Won Park; Yong Chan Ahn; Seung Jae Huh
Journal:  J Gastroenterol       Date:  2006-12-08       Impact factor: 7.527

Review 2.  The therapeutic use of acetaminophen in patients with liver disease.

Authors:  Gordon D Benson; Raymond S Koff; Keith G Tolman
Journal:  Am J Ther       Date:  2005 Mar-Apr       Impact factor: 2.688

3.  Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.

Authors:  Daniel R Wahl; Matthew H Stenmark; Yebin Tao; Erqi L Pollom; Elaine M Caoili; Theodore S Lawrence; Matthew J Schipper; Mary Feng
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

4.  Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium.

Authors:  Vatche G Agopian; Michael P Harlander-Locke; Richard M Ruiz; Goran B Klintmalm; Srinath Senguttuvan; Sander S Florman; Brandy Haydel; Maarouf Hoteit; Matthew H Levine; David D Lee; C Burcin Taner; Elizabeth C Verna; Karim J Halazun; Rita Abdelmessih; Amit D Tevar; Abhinav Humar; Federico Aucejo; William C Chapman; Neeta Vachharajani; Mindie H Nguyen; Marc L Melcher; Trevor L Nydam; Constance Mobley; R Mark Ghobrial; Beth Amundsen; James F Markmann; Alan N Langnas; Carol A Carney; Jennifer Berumen; Alan W Hemming; Debra L Sudan; Johnny C Hong; Joohyun Kim; Michael A Zimmerman; Abbas Rana; Michael L Kueht; Christopher M Jones; Thomas M Fishbein; Ronald W Busuttil
Journal:  Ann Surg       Date:  2017-09       Impact factor: 12.969

5.  2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma.

Authors: 
Journal:  Gut Liver       Date:  2015-05-23       Impact factor: 4.519

6.  Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

Authors:  Hashem B El-Serag; Thomas Tran; James E Everhart
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

7.  Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study.

Authors:  Do Young Kim; Beom Jin Park; Yun Hwan Kim; Kwang-Hyub Han; Sung Bum Cho; Kyu Ran Cho; Sun-Ho Uhm; Jae-Gol Choe; Jong Young Choi; Ho Jong Chun; Han Chu Lee; Dong Il Gwon; Kwang Hun Lee; Jung-Hwan Yoon; Jin Wook Chung; Chang Won Kim; Jeong Heo; Jae Kyu Kim; Young Eun Joo
Journal:  Am J Clin Oncol       Date:  2015-10       Impact factor: 2.339

8.  Randomized controlled trial of screening for hepatocellular carcinoma.

Authors:  Bo-Heng Zhang; Bing-Hui Yang; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2004-07       Impact factor: 4.553

9.  Emergency Department-Initiated Palliative Care in Advanced Cancer: A Randomized Clinical Trial.

Authors:  Corita R Grudzen; Lynne D Richardson; Pauline N Johnson; Ming Hu; Binhuan Wang; Joanna M Ortiz; Emmett A Kistler; Angela Chen; R Sean Morrison
Journal:  JAMA Oncol       Date:  2016-05-01       Impact factor: 33.006

10.  Radiotherapy for Adrenal Metastasis from Hepatocellular Carcinoma: A Multi-Institutional Retrospective Study (KROG 13-05).

Authors:  Jinhong Jung; Sang Min Yoon; Hee Chul Park; Taek-Keun Nam; Jinsil Seong; Eui Kyu Chie; Tae Hyun Kim; Mi-Sook Kim; Chul Yong Kim; Hong Seok Jang; Jong Hoon Kim
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

View more
  80 in total

Review 1.  KASL clinical practice guidelines for management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2019-06-12

2.  A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements.

Authors:  Masatoshi Kudo; Kwang-Hyub Han; Sheng-Long Ye; Jian Zhou; Yi-Hsiang Huang; Shi-Ming Lin; Chung-Kwe Wang; Masafumi Ikeda; Stephen Lam Chan; Su Pin Choo; Shiro Miyayama; Ann Lii Cheng
Journal:  Liver Cancer       Date:  2020-05-13       Impact factor: 11.740

3.  Clinical practice guidelines for hepatocellular carcinoma between Korea, Europe, and United States.

Authors:  Soo Young Park
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-06-30

4.  A New Treatment Option for Intermediate-Stage Hepatocellular Carcinoma with High Tumor Burden: Initial Lenvatinib Therapy with Subsequent Selective TACE.

Authors:  Masatoshi Kudo
Journal:  Liver Cancer       Date:  2019-09-18       Impact factor: 11.740

5.  A New Diagnostic Criterion with Gadoxetic Acid-Enhanced MRI May Improve the Diagnostic Performance for Hepatocellular Carcinoma.

Authors:  Yi Wei; Zheng Ye; Yuan Yuan; Zixing Huang; Xiaocheng Wei; Tong Zhang; Shang Wan; Hehan Tang; Xiaopeng He; Bin Song
Journal:  Liver Cancer       Date:  2020-04-14       Impact factor: 11.740

6.  Balloon-Occluded Transarterial Chemoembolization: In Which Size Range Does It Perform Best? A Comparison of Its Efficacy versus Conventional Transarterial Chemoembolization, Using Propensity Score Matching.

Authors:  Rita Golfieri; Mario Bezzi; Gontran Verset; Fabio Fucilli; Cristina Mosconi; Alberta Cappelli; Alexandro Paccapelo; Pierleone Lucatelli; Nicolas Magand; Agnes Rode; Thierry De Baere
Journal:  Liver Cancer       Date:  2021-07-14       Impact factor: 11.740

7.  Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver disease.

Authors:  Ji Hae Nahm; Hye Sun Lee; Haeryoung Kim; Sun Young Yim; Ji-Hyun Shin; Jeong Eun Yoo; Sang Hoon Ahn; Jin Sub Choi; Ju-Seog Lee; Young Nyun Park
Journal:  Liver Int       Date:  2021-03-25       Impact factor: 5.828

8.  Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma.

Authors:  Jeong-Won Jang; Jin-Seoub Kim; Hye-Seon Kim; Kwon-Yong Tak; Soon-Kyu Lee; Hee-Chul Nam; Pil-Soo Sung; Chang-Min Kim; Jin-Young Park; Si-Hyun Bae; Jong-Young Choi; Seung-Kew Yoon
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

9.  Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma.

Authors:  Han Ah Lee; Young-Sun Lee; Beom Kyung Kim; Young Kul Jung; Seung Up Kim; Jun Yong Park; Ji Hoon Kim; Hyunggin An; Do Young Kim; Hyung Joon Yim; Sang Hoon Ahn; Jong Eun Yeon; Kwan Soo Byun; Kwang-Hyub Han; Soon Ho Um; Yeon Seok Seo
Journal:  Gut Liver       Date:  2021-05-15       Impact factor: 4.519

Review 10.  Role of modern radiotherapy in managing patients with hepatocellular carcinoma.

Authors:  Liang-Cheng Chen; Hon-Yi Lin; Shih-Kai Hung; Wen-Yen Chiou; Moon-Sing Lee
Journal:  World J Gastroenterol       Date:  2021-05-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.